Marc Beer is called upon and delivers when it comes to finding business solutions and developing strategies to not only improve but boost companies into success.
With a vast background in leadership and a superior education from the University of Miami, his career path led him into pharmaceutical sales and marketing. He is driven by his devotion to the field, natural business talent, as well as his desire to support the inadequately served population with rare medical diseases.
It was his role as Vice President of Global Marketing at Genzyme that propelled his career and led him to become an entrepreneur. Viacell, a biotechnology company, was his first company that launched in 2000. It was his drive and motivation and helped this company find success in cutting edge technology and medical advances with the preservation of umbilical cord blood stem cells for development and use to treat a variety of conditions in the human body including Parkinson’s Disease. Beer sold this company seven years later to PerkinElmer for $300 million. PerkinElmer continues to explore Beer’s concepts and made medical advances through stem cell research and regenerative medicine.
Through triumph and turbulence including the untimely death of his wife, Beer continued to balance family life with his career. After a couple of years of focusing on his children after his wife’s passing, was when his 14-year-old daughter encouraged him to put more time and effort into his second passion, business, and medical advances.
It was at this time, he found himself partnered with Dr. Iglesias and Yolanda Lorié to found Renovia. Once again, Beer took his passion for helping others, researching innovative ways to medically support disorders and diseases that impact the lives of others and co-founded Renovia. Renovia focuses on pelvic floor disorders that impact 25% of women. It was the leadership in Beer and the motivation Dr. Iglesias in finding an alternative treatment to surgical interventions that birthed this company. Millions of women have been helped by Renovia’s breakthrough preventative and therapeutic interventions.
Seven years later, Beer as the co-founder and CEO finds himself and his team of experts Nominated for MedTech Company of the Year at the New England Venture Capital Association’s 2019 NEVYs Awards.
Through triumph and turmoil, failures and successes, Marc Beer’s humble approach to his life and his accomplishments pharmaceuticals and medical advances makes a likable person but is a depiction of what true leadership is. Learn more: https://renoviainc.com/leadership/